Henry A. Glick
Value in Health · 2005–2015
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Henry A. Glick's perspective
Ordered by how strongly the researchers Henry A. Glick trusts endorse each paper. Same corpus, a different order for every researcher.
- Representing uncertainty: the role of cost-effectiveness acceptability curves. (Health Economics)
- Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. (Value in Health)
- Cost-effectiveness in health and medicine
- Statistical Analysis With Missing Data
- Analysis of Incomplete Multivariate Data (Technometrics)
- Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (British medical journal)
- The estimation of a preference-based measure of health from the SF-36. (Journal of Health Economics)
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (British medical journal)
- The effect of patient race and socio-economic status on physicians' perceptions of patients. (Social Science & Medicine (1967))
Their papers
- Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. (2005) — 728 citations
- Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. (2015) — 705 citations
- A randomized, controlled trial of financial incentives for smoking cessation. (2009) — 898 citations